Economy

Sarepta Therapeutics, Inc. (SRPT) Trading Down 0% on Insider Selling

The stock declined 0.63% or $0.89 reaching $140.43 per share. Mutual of America Capital Management LLC now owns 60,108 shares of the company's stock valued at $2,319,000 after buying an additional 358 shares in the last quarter. Johnson & Johnson now has $377.27B valuation. Investors saw a positive move of 6.18% in last five trading days. Sarepta Therapeutics Inc (NASDAQ:SRPT) has risen 96.82% since November 9, 2016 and is uptrending. It has outperformed by 80.12% the S&P500. Eagle Asset Management Inc. boosted its position in shares of Sarepta Therapeutics by 33.4% during the second quarter.

SRPT is now undervalued by -24.26% relative to the average 1-year price target of $69.24 taken from a group of Wall Street Analysts. BlackRock Inc. now owns 5,292,729 shares of the biotechnology company's stock valued at $156,664,000 after purchasing an additional 5,175,193 shares in the last quarter. Sarepta Therapeutics has a one year low of $8.00 and a one year high of $63.73. Oppenheimer Holdings now has a "Buy" rating and a $76.00 price target on the stock.

About 3.10M shares traded or 40.27% up from the average. Columbus Circle Investors now owns 121,758 shares of the biotechnology company's stock worth $5,457,000 after acquiring an additional 73,395 shares during the period. Array Biopharma Inc (NASDAQ:ARRY) was raised too.

Investors sentiment increased to 1.52 in 2017 Q2. Its up 0.09, from 1.43 in 2017Q1. Hedge funds and other institutional investors own 65.58% of the company's stock. 30 funds opened positions while 61 raised stakes. The Ontario - Canada-based Canada Pension Plan Investment Board has invested 0% in Sarepta Therapeutics Inc (NASDAQ:SRPT). Ameritas Investment Partners Inc holds 4,561 shares. Camber Cap Mngmt Limited Liability Corp has 1.30M shares. Geode Capital Management Ltd Llc has 0.01% invested in Sarepta Therapeutics Inc (NASDAQ:SRPT) for 446,269 shares.

Traders have different rules for what constitutes liquidity and a good guide is the volume of trades and volume of shares that are traded each day. Active Investors often continue a close observation on any stock volume. During the same period in the prior year, the company earned ($0.95) EPS. equities research analysts expect that Sarepta Therapeutics will post -3.11 EPS for the current fiscal year. Shares of ICON Public Limited Company (ICLR) weakened with poorly motion. Tiaa Cref Lc reported 166,089 shares. This presents short term, intermediate and long term technical levels of Sarepta Therapeutics, Inc. Virginia-based Thompson Davis has invested 0.01% in Vanda Pharmaceuticals Inc. Parametric Portfolio Assocs Limited Liability Com holds 0% or 36,919 shares. Architects Inc holds 0.01% or 5,000 shares in its portfolio. The average investment recommendation on a scale of 1 to 5 (1 being a strong buy, 3 a hold, and 5 a sell) is 1.80, which implies that analysts are generally bullish in their outlook for SRPT over the next year. Therefore 100% are positive. Cowen & Co maintained Sarepta Therapeutics Inc (NASDAQ:SRPT) rating on Tuesday, September 12. The company was upgraded on Monday, October 2 by Morgan Stanley.

Investors now seemed to have turned increasingly nervous following the Washington Post report on Tuesday, suggesting that Senate Republicans may delay corporate tax cut by 1-year. As per Wednesday, March 9, the company rating was maintained by JMP Securities. The rating was maintained by Roth Capital with "Buy" on Thursday, August 20.

Jason Karp decreased its stake in Sarepta Therapeutics Inc (Put) (SRPT) by 6.3% based on its latest 2017Q2 regulatory filing with the SEC. Leerink Swann reiterated an "outperform" rating and issued a $66.00 target price on shares of Sarepta Therapeutics in a research note on Saturday, September 30th. Needham maintained it with "Buy" rating and $55 target in Friday, October 2 report. One equities research analyst has rated the stock with a sell rating, six have assigned a hold rating and sixteen have given a buy rating to the company. Oclaro Inc had 38 analyst reports since August 18, 2015 according to SRatingsIntel. Jefferies maintained it with "Buy" rating and $1200 target in Friday, June 9 report. The rating was maintained by Oppenheimer on Thursday, August 3 with "Buy". Finally, Piper Jaffray Companies reissued an "overweight" rating and set a $55.00 price objective (up from $50.00) on shares of Sarepta Therapeutics in a report on Thursday, September 7th. The rating was maintained by Oppenheimer on Wednesday, April 6 with "Outperform". The firm has "Buy" rating given on Monday, September 11 by Piper Jaffray. The firm earned "Buy" rating on Thursday, October 6 by Jefferies. Needham maintained Oclaro Inc (NASDAQ:OCLR) rating on Wednesday, February 3. This number is based on a 1 to 5 scale where 1 indicates a Strong Buy recommendation while 5 represents a Strong Sell.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.



Like this

Latest


10 November 2017
Bulls Picked as NBA All-Star Game Host
Cleveland had previously been vying to host the league's next available All-Star Game, targeting the 2020 and 2021 exhibitions. Chicago went on to win the first of three straight championships just two seasons after hosting the game from 1990-93.

10 November 2017
Tesla and SpaceX chief Elon Musk meets Erdogan in Turkey
Tesla founder met with the Turkish President Recep Tayyip Erdogan and several top officials in Ankara . The presidential office did not immediately provide details on meeting at Erdogan's palace complex.

10 November 2017
Remi Garde: Ex-Aston Villa boss named new Montreal Impact manager
Garde, 51, earned plaudits as coach at this home club Olympique Lyonnais, winning the French Cup and Super Cup in 2012. Montreal Impact have appointed Remi Garde as the club's new head coach and director of player personnel.

10 November 2017
Air Lease Corporation Earnings & Price Target Update
Looking at some alternate time periods, the 12 month price index is 0.98520, the 24 month is 0.90650, and the 36 month is 1.17511. Following the completion of the sale, the executive vice president now owns 142,786 shares in the company, valued at $5,711,440.

10 November 2017
Eleague unveils Rocket League tournament
A feature series will also be produced as a kind of documentary throughout the competition. That tournament will continue across streaming platforms throughout that weekend.

10 November 2017
Hyderabad police bans begging ahead of Global Entrepreneurship Summit
The police's desire to get the city spruced up for Trump's visit prompted the relocation of approximately 400 beggars to a rehabilitation center, reported The Indian Express .

10 November 2017
When Will 'Star Trek: Discovery' Return?
But it's really not that long of a wait-Season 1, Chapter Two will be available starting Sunday, Jan. 7, 2018, after 8:30pm ET. Star Trek: Discovery's first season continues this Sunday at 8:30 PM ET on CBS All Access with " Into The Forest I Go ".

10 November 2017
US Blacklists Cuban Firms, Restricts American Travel to the Island
Marco Rubio told reporters that he wants the list to be longer and include the Gran Caribe Hotel Group and Cubanacan. The administration took several months to finalize the details of the new rules, which will take effect Thursday.

10 November 2017
Stream every 'Harry Potter' film on HBO starting January 1st
To welcome the franchise properly, HBO will host a marathon starting on the morning of January 1 and ending the following day. They will also air back-to-back on New Year's Day - commercial free, this is HBO after all - to ring in the new year.

10 November 2017
Panthers' Olsen to test broadcasting skills for Fox
Carolina Panthers tight end Greg Olsen is getting another jump on his broadcasting career this week with his team on a bye. For this gig, Olsen will be in a three-man booth alongside play-by-play man Kevin Burkhardt and analyst Charles Davis.



Recommended